Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 1,000 shares at $19.11 ($19K) on 2016-04-11, disclosed to the SEC on 2016-04-13.
Scheduled sale ($19k) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |
| RVNC | SELL | 2016-01-08 | $66K | — | Filing → |